Nov 18, 2009
Tulane Cancer Center To Begin Novel Clinical Trial For Late-Stage Prostate Cancer Drug
International prostate cancer expert Dr. Oliver Sartor of Tulane Cancer Center is the first oncologist in the United States to offer patients an experimental new treatment for late-stage prostate cancer through a multi-center clinical trial that is currently recruiting patients at 100 sites across 20 countries worldwide